Gerresheimer AG Investor Relations:
Your Hub for Financial Insights and Updates
Quick Video Briefs
By loading the video, you agree to our Terms & Conditions,
our Privacy Policy and Vimeo's privacy policy.
Gerresheimer is a global partner to the pharma, biotech, and cosmetics industries, offering pharmaceutical containment solutions, drug delivery systems, and medical devices. With 35 production sites in 16 countries and around 12,000 employees, the company generated revenues of approximately €2bn in 2023. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6)
Video Hub
At a Glance
Gerresheimer is an innovative systems and solutions provider and a global partner to the pharma, biotech, and cosmetics industries. The company offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems and medical devices as well as solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, ampoules, tablet containers, infusion, dropper and syrup bottles, and more. With 35 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. With around 12,000 employees, the company generated revenues of around €2bn in 2023. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).